INVO (invobioscience.com) Market Value to Book Value Ratio

invobioscience.com (INVO) - corporate logo

INVO Bioscience, Inc. (INVO) net income is transforming alongside the transition to AI-driven real estate lending services and the rebranding to Janover. The price-to-book ratio clearly demonstrates this trend, with the parameter stabilizing at -0.11. Environmental policy is based on clean assembly standards, while the engineering team strives to make infertility treatment more accessible.

Market Capitalization to Net Assets: invobioscience.com (INVO) for 07/04/2022 - 04/28/2025
Finished products of INVO Bioscience, Inc.

This indicator compares current market value with balance sheet equity to identify systemic risks. Analyzing the ratio between the company's market valuation and its book value determines the degree of price overheating relative to net assets. A high premium signals inflated expectations and the probability of a correction. For INVO Bioscience, Inc. (INVO), such a valuation reflects market confidence in the efficiency of INVOcell assembly cell robotization. The implementation of AI control and automated biopolymer casting justifies the current investment discount.

Direct competitors

Market Value to Book Value Ratio BSX|EW (edwards.com) - Market-to-Book Ratio|RMD: Market Value to Book Value Ratio|Market Capitalization to Book Value PODD|ZBH - Market Value to Book Value Ratio|Market Capitalization to Net Assets CooperSurgical (COO)|ALGN: Market Capitalization to Book Value Ratio|Market-to-Book Ratio globusmedical.com GMED|TMDX: Market Capitalization to Book Value Ratio|ATEC - Market Cap to Net Assets Ratio|Artivion Inc - Market Capitalization to Book Value Ratio|Enovis Inc. (ENOV) - Market Capitalization to Book Value|IART (Integra LifeSciences) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio ESTA|Market Value to Book Value Ratio Beta Bionics (BBNX)|Market Value to Book Value Ratio IRADIMED Corp (IRMD)|Market Capitalization to Book Value Ratio EMBC|TNDM - Market Capitalization to Book Value|Market Cap to Net Assets Ratio AxoGen, Inc.|SIBN - Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio OFIX|Bioventus Inc (BVS) - Market-to-Book Ratio|Market Capitalization to Book Value Ratio OrthoPediatrics Corp (KIDS)|Capitalization to Book Value Ratio Treace Corp (TMCI)|Strata Critical Medical Inc (SRTA) - Market Cap to Net Assets Ratio|Market Value to Book Value CARL (carlsmed.com)|RxSight - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio ClearPoint Neuro Inc. CLPT|STXS (Stereotaxis Corp) - Market Capitalization to Book Value Ratio|STIM - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Sight Sciences, Inc.|orchestrabiomed.com (OBIO) - Capitalization to Book Value Ratio|ANIK: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value InspireMD Inc|Market Capitalization to Book Value Ratio ZJYL (Jin Medical International)|Market Cap to Net Assets Ratio vivani.com (VANI)|Market Capitalization to Book Value Ratio XTNT (Xtant Medical)|n1mtc.com - Market Capitalization to Book Value Ratio|MODD - Market Value to Book Value Ratio|Myomo Inc. (MYO) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Envoy Medical, Inc COCH|Vivos Therapeutics Inc (VVOS) - Market Value to Book Value|Market Capitalization to Book Value Ratio NVNO (enVVeno Medical)|Market-to-Book Ratio SINT|TNON: Market Value to Book Value Ratio|Market Value to Equity Ratio ReWalk Robotics LFWD|Market Cap to Net Assets Ratio AMIX (Autonomix Medical)|Market Capitalization to Book Value Ratio INVO Fertility Corp IVF|Market Capitalization to Book Value Ratio BBLG (Bone Biologics)|AXNX: Market Capitalization to Book Value|Market Value to Book Value Ratio BIOLASE (BIOL)|DYNT (Dynatronics) - Market Capitalization to Net Assets|Market Value to Book Value Ratio FNA